The collaboration will focus on preventive solutions, workshops, and public awareness. King Faisal Specialist Hospital and ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

It's a daycare procedure and doesn't require hospitalisation. However, it is an expensive treatment. Will my health insurance ...

About AXPAXLI AXPAXLI™ (axitinib intravitreal injection, also known as OTX-TKI) is an investigational, bioresorbable, hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase ...

Diabetic retinopathy is a common complication in people with type 1 and type 2 diabetes, progressing from mild, moderate, and ...

Striking a balance between innovation and responsibility is imperative. By prioritizing transparency, adhering to robust ...

Towards the end of life, you might want to make decisions about your care. This includes any instructions for refusing treatment. It can sometimes be very difficult to know what care and treatment to ...

The phase 3 trial showed biosimilar CT-P42 (Celltrion) is therapeutically equivalent to reference aflibercept in improving visual acuity in patients with diabetic macular edema (DME), with comparable ...

A recent cohort study revealed low adoption of FDA-approved AI-based diabetic retinopathy detection, with less than 5% of diabetic patients receiving ophthalmic imaging. Researchers emphasize the need ...

Avoid the most common diabetes complications with these helpful tips. Insulin is the main treatment for type 1 and 1.5 diabetes. It replaces the hormone your body isn’t able to produce.

While many types of dermatitis can be managed at home without medical treatment, you should consult a healthcare provider if you have any type of dermatitis with the following characteristics: ...